Skip to main content
NewslettersWatchlist

Charles River Laboratories Intl(CRL-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low225.97
Day High237.31
Open:237.31
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Rebound as Bond Yields Fall on Dovish Fed Comments
Barchart
Stocks Rebound as Comments from Fed’s Goolsbee Knock Bond Yields Lower
Barchart
Stocks Finish Mixed as a Slump in Intel Weighs on the Overall Market
Barchart
Broader Market Gains on Goldilocks U.S. Economy
Barchart
Surging Bond Yields Hammer Stocks
Barchart
Stocks Slump and Bond Yields Climb on Fed Jitters
PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)
Barchart
Stocks Close Lower Ahead of Thursday’s U.S. CPI Report
Barchart
Stocks Slip on Weakness in Chip Stocks
PR Newswire
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
PR Newswire
Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
PR Newswire
CRL DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
PR Newswire
CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options
PR Newswire
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
PR Newswire
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
PR Newswire
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
PR Newswire
CRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR Newswire
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Charles River Laboratories International, Inc. - CRL
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
PR Newswire
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
PR Newswire
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
PR Newswire
CRL Investors Have Opportunity to Lead Charles River Laboratories International, Inc. Securities Fraud Lawsuit
PR Newswire
CRL INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on July 18, 2023 in Securities Fraud Class Action Lawsuit Filed against Charles River Laboratories International, Inc.
PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023
PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Secure Counsel Before Important July 18 Deadline in Securities Class Action - CRL
PR Newswire
CHARLES RIVER DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charles River To Contact Him Directly To Discuss Their Options
PR Newswire
CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Charles River Laboratories
PR Newswire
CRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River Shareholders of a Lead Plaintiff Deadline of July 18, 2023
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
PR Newswire
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Charles River Investors of a Lead Plaintiff Deadline of July 18, 2023

Profile

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.